CustomVue offers good results in mixed astigmatism

Article

Excellent visual outcomes can be achieved in subjects with mixed astigmatism when using the VISX wavefront platform's CustomVue iris registration system (AMO).

Excellent visual outcomes can be achieved in subjects with mixed astigmatism when using the VISX wavefront platform's CustomVue iris registration system (AMO), according to Baha Toygar and co-workers from the Dunya Eye Hospital, Istanbul, Turkey.

Sixteen eyes with mixed astigmatism were enrolled into the prospective study in which all LASIK procedures were performed by the same surgeon.

Three months following surgery, mean astigmatism had reduced from -3.14±1.06 D to -0.33±0.44 D. The majority of eyes (81%) had less than -0.50 D residual astigmatism and 87.5% had less than -1.0 D. Mean uncorrected and best corrected visual acuity (UCVA & BCVA) improved from 0.24±0.13 to 0.79±0.27 and from 0.84±0.20 to 0.95±0.11, respectively.

Overall, these results demonstrate that the VISX wavefront platform's CustomVue iris registration system can offer excellent visual outcomes for subjects with mixed astigmatism.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.